KWS SAAT & (KWS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Sep, 2026Strategic positioning and growth drivers
Focus on innovation in plant breeding, leveraging a heritage since 1856 and a broad crop portfolio for sustainable, profitable growth.
Addresses global agricultural challenges with resilient varieties, digital solutions, and input reduction.
Growth driven by leadership in field crops, expansion in high-value segments like vegetables and food ingredients, and advanced trait development.
Strong R&D investment (€342m, 38% of employees in R&D) and over 500 new variety approvals in FY 2025/26.
Capital allocation balances organic growth, M&A, and increasing dividends, with a payout ratio target of 25-30%.
Financial performance and segment highlights
FY 2025/26 net sales at €1,627m (-1% YoY), EBITDA €343m (-2%), and net income €158m (+13%).
Sugarbeet segment: €854m sales, 42% EBITDA margin, 63% of sales from innovations like CONVISOⓇ SMART and CR+.
Corn segment: €434m sales, 21% EBITDA margin, market share gains in Europe, and €29m one-off from license sale.
Cereals segment: €264m sales, 13% EBITDA margin, strong rapeseed growth (+24%), but declines in rye, wheat, and barley.
Vegetables segment: €68m sales, negative EBITDA due to investment in breeding and sales, with a focus on pipeline expansion.
Innovation and technology
Track record of first-in-class inventions, including disease resistance and herbicide tolerance traits.
Hybridization and genome editing accelerate trait development, enabling faster market entry and higher value capture.
Technology backbone includes bioinformatics, genomics, digital phenotyping, and CRISPR.
Development of new varieties takes up to 10 years, with a robust pipeline supported by 527 new approvals in FY 2025/26.
Latest events from KWS SAAT &
- Profitability held steady with net income up 13% despite a 3% sales drop; outlook is positive.KWS
Q4 2026 - Innovation-led growth, strong cashflow, and higher dividends highlight resilient performance.KWS
Investor presentation - EBITDA rose 7.2% to €386.8M, driven by organic growth and a €29M one-off gain.KWS
Q3 2026 - Stable sales and a special gain drove improved earnings, with margin outlook confirmed.KWS
Q2 2026 - Aims for 3%-5% organic growth, 19%-21% EBITDA margin, and innovation-driven crop leadership.KWS
CMD 2025 - EBITDA turned positive on a €30M one-off gain, despite an 8.2% sales drop in Q1 2025/2026.KWS
Q1 2026 - Double-digit growth, strategic divestments, and a higher dividend highlight strong performance.KWS
Q4 2024 - Vegetable seeds and climate-adaptive breeding drive long-term growth and innovation.KWS
New Food Conference - Net income surged 56% on stable sales, driven by a major business divestment.KWS
Q3 2025